Science Explorer Interactive view Map
Institution · Toronto · Canada

Leukemia & Lymphoma Society of Canada

World rank, all time
#38,811
of 42,892
Rank in Canada
#840
of 896
Research works
128
▼ 13% vs 2013–17
Citations
2.2k
17.0 per fractional work
Top-10% rate
6.9%
record average 16.5%
Open access
35%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.14× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.88× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 2.52× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 2.93× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.49× its world share, 1 worksComputer ScienceEnergy: 2.25× its world share, 0 worksEnergyEngineering: 0.03× its world share, 0 worksEngineeringHealth Professions: 1.11× its world share, 0 worksHealth ProfessionsMedicine: 3.38× its world share, 10 worksMedicineNursing: 4.22× its world share, 0 worksNursingBusiness, Management and Accounting: 0.69× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 1.61× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.30× its world share, 1 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Nursing, 4.2×. Every wedge is a field page.

Which keywords describe research at Leukemia & Lymphoma Society of Canada?

By fractional works in all years, weighted toward what it does more of than the world: Prognostic Factors, Hematopoietic Stem Cells, Acute Myeloid Leukemia, AML, Rituximab, Lymphoma, Mesenchymal Stem Cells and BCR-ABL.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Prognostic Factors18▲ 31×6 topics
  2. Hematopoietic Stem Cells17▲ 129×3 topics
  3. AML11▲ 178×1 topic
  4. Acute Myeloid Leukemia11▲ 178×1 topic
  5. Rituximab8▲ 38×3 topics
  6. Lymphoma6▲ 31×3 topics
  7. Human Rights6▲ 5.4×12 topics
  8. BCR-ABL6▲ 161×1 topic
  9. Imatinib6▲ 161×1 topic
  10. Mesenchymal Stem Cells6▲ 38×3 topics
  11. Bone Marrow Niche6▲ 129×1 topic
  12. Graft-versus-Host Disease6▲ 129×1 topic
  13. Property Rights5▲ 37×3 topics
  14. Cancer5▲ 2.7×13 topics
  15. Chemotherapy5▲ 5.5×12 topics
  16. Contract Law5▲ 95×2 topics
  17. Minimal Residual Disease5▲ 58×2 topics
  18. Corrective Justice5▲ 146×1 topic
  19. Remedies5▲ 146×1 topic
  20. Classification4▲ 9.3×2 topics
  21. Chronic Lymphocytic Leukemia4▲ 66×1 topic
  22. Genomic Aberrations4▲ 66×1 topic
  23. PET Imaging4▲ 14×4 topics
  24. Immunotherapy4▲ 4.7×8 topics
  25. Genetic Pathogenesis4▲ 47×1 topic
  26. International Law4▲ 10×6 topics
  27. Molecular Profiling4▲ 24×1 topic
  28. Prognostic Scoring System3▲ 70×2 topics
  29. Staging System3▲ 35×2 topics
  30. Proteasome Inhibitors3▲ 30×2 topics
  31. Diagnosis Criteria3▲ 68×1 topic
  32. International Myeloma Working Group3▲ 68×1 topic
  33. JAK2 Mutation2▲ 92×1 topic
  34. Leukemia2▲ 28×2 topics
  35. Myelofibrosis2▲ 92×1 topic
  36. Acute Lymphoblastic Leukemia2▲ 49×1 topic
  37. Childhood Cancer2▲ 49×1 topic
  38. European Union2▲ 6.9×2 topics
  39. Immigration2▲ 14×2 topics
  40. Cancer Immunotherapy2▲ 12×2 topics

Which research topics does Leukemia & Lymphoma Society of Canada publish most on?

By volume in 2022–2025: Acute Myeloid Leukemia Research, Global Cancer Incidence and Screening, Hematopoietic Stem Cell Transplantation and Chronic Myeloid Leukemia Treatments.

  1. 1 Acute Myeloid Leukemia Research Hematology 1 works
  2. 2 Global Cancer Incidence and Screening Oncology 1 works
  3. 3 Hematopoietic Stem Cell Transplantation Hematology 1 works
  4. 4 Chronic Myeloid Leukemia Treatments Hematology 1 works
  5. 5 Chronic Lymphocytic Leukemia Research Genetics 0 works
  6. 6 Neutropenia and Cancer Infections Oncology 0 works
  7. 7 CAR-T cell therapy research Oncology 0 works
  8. 8 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 0 works
  9. 9 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  10. 10 Dermatologic Treatments and Research Dermatology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available34.7%not open65.3%

World: 28% of research is openly available.

with international co-authors28.7%domestic only71.3%

World: 19% is written across borders.

How has Leukemia & Lymphoma Society of Canada's research output changed?

Output in 2018–2022 was 13% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Toronto

All research institutions in Toronto

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.